Skip to main content
Vivek Shah, MD, Internal Medicine, Sylmar, CA, Olive View-UCLA Medical Center

VivekShahMD(He/Him)

Internal Medicine Sylmar, CA

Hematology/Oncology

Hematology & Oncology Fellow

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shah's full profile

Already have an account?

Education & Training

  • Olive View/UCLA Medical Center
    Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
  • Loma Linda University Health Education Consortium
    Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 2019 - 2022
  • Oakland University William Beaumont School of Medicine
    Oakland University William Beaumont School of MedicineClass of 2019
  • University of Southern California
    University of Southern CaliforniaBS, Business Administration, Magna Cum Laude, 2009 - 2013

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2026
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Undergraduate Provost's Research Fellowship University of Southern California, 2011-2012

Publications & Presentations

PubMed

Journal Articles

  • Convalescent Plasma for COVID-19: A Single Center Prospective Experience with Serial Antibody Measurements and Review of the Literature  
    Sonia N. Whang, Vivek D. Shah, Lu Pu, Parthiv Sheth, Gina N. Lucas, Joanne Lee, Michael Lee, Curtis Lacy, Penelope J. Duerksen-Hughes, Valeri Filippov, David J. H. Lee..., Pathogens, 8/23/2022
  • Torsades de Pointes due to Excessive Marijuana Use in a Susceptible Patient  
    Vivek D. Shah, MD, Adeba Mohammad, DO, Shuktika Nandkeolyar, MD, Liset Stoletniy, MD, Tahmeed Contractor, MD, Case Reports in Cardiology, 6/14/2021
  • Primary Chemoradiation With Cisplatin Versus Cetuximab for Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study  
    Il Seok Daniel Jeong, BS; Huan Mo, MD; Anthony Nguyen, MD; Esther Chong, MD; Justin Moyers, MD; Matthew Kim, DO; Hsin Hsiang Clarence Tsai, BS; Vivek Shah, MD; Bobae K..., Experimental Hematology & Oncology, 8/5/2020
  • Join now to see all

Abstracts/Posters

  • The Deadly Vape: THC-Vaping Related Torsades de pointes
    Vivek D. Shah, Adeba Mohammad, Shuktika Nandkeolyar, Tahmeed Contractor, Liset Stoletniy, American College of Cardiology, Chicago, IL, 3/28/2020

Research History

  • Local Principal Investigator- US Expanded Access Program for Convalescent Plasma for the Treatment of Patients with COVID-19Worked alongside an interdisciplinary hematology/oncology team to recruit patients who recovered from COVID-19 to donate convalescent plasma (CP). In addition, I documented the outcomes of patients who received CP to analyze the utility of CP in recovery from COVID-19.2020 - 2022

Other Languages

  • Gujarati, Spanish

Hospital Affiliations